Skip to main content
CNC
NYSE Life Sciences

Centene Projects FY Revenue of $187.5B-$191.5B

feedReported by Dow Jones Newswires
Sentiment info
Neutral
Importance info
7
Price
$45.9
Mkt Cap
$21.397B
52W Low
$25.075
52W High
$64.15
Market data snapshot near publication time

summarizeSummary

Centene Corporation has issued its full-year revenue guidance, projecting a range of $187.5 billion to $191.5 billion. This forward-looking financial update is a key data point for investors, particularly as it follows the company's reported GAAP net loss of $6.67 billion for fiscal year 2025, which included a significant goodwill impairment. Traders will closely evaluate this guidance against analyst consensus to gauge the company's expected financial trajectory and potential for operational improvement. The market will now focus on the underlying drivers of this revenue outlook and any subsequent updates on profitability.

At the time of this announcement, CNC was trading at $45.90 on NYSE in the Life Sciences sector, with a market capitalization of approximately $21.4B. The 52-week trading range was $25.08 to $64.15. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


show_chartPrice Chart

Share this article

Copied!

feed CNC - Latest Insights

CNC
Apr 28, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
CNC
Apr 27, 2026, 8:08 PM EDT
Filing Type: 8-K
Importance Score:
8
CNC
Apr 27, 2026, 8:07 PM EDT
Filing Type: 10-Q
Importance Score:
8
CNC
Mar 26, 2026, 4:26 PM EDT
Filing Type: DEF 14A
Importance Score:
8
CNC
Mar 10, 2026, 1:11 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
CNC
Mar 09, 2026, 6:20 PM EDT
Filing Type: 8-K
Importance Score:
8
CNC
Feb 17, 2026, 4:31 PM EST
Filing Type: 10-K
Importance Score:
9
CNC
Feb 05, 2026, 8:52 PM EST
Filing Type: 8-K
Importance Score:
8